Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Remtec Search

    The specialist European Medical Device and Life Science recruitment company, working internationally to assist candidates and clients from across the world. Remtec offers 2 main services: Executive search and Contingency selection focusing on sales, marketing and technical roles. Our extensive experience, combined with proven processes, allows us to offer an unprecedented service to employers seeking top quality candidates and to candidates seeking top quality employers.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    - PMLiVE

    M3 (EU)

    M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

    View Profile

    Digital communications, Medical education, Recruitment and career development

    Company Details

    Remtec Search
    Remtec Search and Selection Ltd, Registered Office, Breaks House, Mill Court, Cambridge, CB22 5LD, United Kingdom
    +44 (0)1223 550 860
    Contact Remtec Search
    Website

     Latest Content from PMHub 

    How to confirm customer understanding in e-detailing

    White Papers and Resources | February 12, 2015 | Anthill Agency

    Done right, e-detailing takes away the guesswork in your marketing.

    The storytelling method that works for e-detailing

    White Papers and Resources | February 6, 2015 | Anthill Agency

    You hear so much spoken about storytelling in digital communication that it’s easy to be skeptical. After all what exactly does it mean? And how – precisely – do you...

    How the focus on patient outcomes has allowed FMCG to enter into healthcare market

    White Papers and Resources | February 5, 2015 | Blue Latitude Health

    Associate Consultant Mette Drabæk talks about how the increase in ability to measure real-world patient outcomes has strengthened the position of the payer when negotiating reimbursement contracts with pharma companies.

    Webinar series: E-detailing content that works

    White Papers and Resources | February 4, 2015 | Anthill Agency

    E-detailing and closed loop marketing is too often seen as a technical issue rather than a creative one. Yet to get the most from the technology you need to have...

    Why e-detailing must give options to healthcare professionals

    White Papers and Resources | January 20, 2015 | Anthill Agency

    We know, we know. You want to talk about your treatment right away, but this really is an essential step that will make your e-detailing even more credible.

    Top 7 Trends in Pharma Marketing for 2015

    White Papers and Resources | January 12, 2015 | Blue Latitude Health

    Toward the end of 2014 the Blue Latitude team gathered together for breakfast in the boardroom to discuss how pharma marketing will change in the year ahead and what trends...

    Blue Latitude boosts its team

    Press Releases | January 6, 2015 | Blue Latitude Health

    Blue Latitude has appointed Ben Routley, Natalie Seebeck and Kasia Zygadlewicz to its team, following a series of new business wins and increased work from existing clients.

    Pegasus picks up “Specialist Consultancy of the Year” at the PRCA Awards 2014

    Press Releases | December 8, 2014 | Inizio

    Pegasus, the UK’s leading independent health communications consultancy, picked up the “Specialist Consultancy of the Year” award at the PRCA Awards 2014.

    Pegasus supports unique theatrical performance as part of the 9th UK Dementia Congress

    Press Releases | November 14, 2014 | Inizio

    Brighton-based Pegasus, the UK’s leading independent health communications consultancy, is pleased to be supporting Naomi’s Flight - a bold and unique theatrical performance tour that highlights the impact of dementia...

    10 Remapping the Market

    White Papers and Resources | November 14, 2014 | Havas Lynx

    Does pharma's global model need a shake up?